A

Apexigen

29 employees

Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Pharmaceutical
Biopharma

Date founded

2010

Funding rounds raised

Total raised

$65M

from 10 investors over 10 rounds

A

Apexigen raised $65M on March 24, 2020

Investors: Oceanpine Capital, VI Ventures, SV Tech Ventures, Decheng Capital and 3E Bioventures Capital

A

Apexigen raised $58M on August 8, 2018

Investors: VI Ventures, 3E Bioventures Capital and SV Tech Ventures

A

Apexigen raised $15M on August 8, 2018

Investors: Decheng Capital

A

Apexigen raised $20M on August 6, 2013

Investors: AMKEY VENTURES LLC

FAQ